Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
181 studies found for:    Open Studies | "Blood Platelet Disorders"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Thrombocytopathy in Gaucher Disease Patients
Conditions: Gaucher Disease;   Thrombocytopathy
Intervention:
2 Recruiting Relationship Between Level of Hemoglobin A1c and Platelet Function in Patients Undergoing Cardiac Surgery
Conditions: Diabetes Mellitus;   Complication of Coronary Artery Bypass Graft;   Blood Platelet Disorders
Intervention:
3 Not yet recruiting Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder
Condition: Inherited Platelet Disorders
Intervention: Other: Blood collection for platelet protein samples
4 Not yet recruiting Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy
Conditions: Hemorrhage, Surgical;   Hip Replacement, Total;   Thrombocytopathy
Interventions: Drug: Gelofusine® B. Braun;   Drug: Ringerfundin ® B. Braun
5 Unknown  Safety and Efficacy of Eltrombopag at Escalated Doses
Conditions: Immune Thrombocytopenia;   Platelet Disorder
Interventions: Drug: Eltrombopag;   Drug: Placebo
6 Recruiting Eltrombopag for Inherited Thrombocytopenias
Condition: Inherited Platelet Disorder
Intervention: Drug: Eltrombopag
7 Not yet recruiting Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone
Conditions: ITP;   Croticosteroid Therapy
Interventions: Drug: High dose Dexamethasone pulses;   Drug: Prednisone
8 Recruiting Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure
Conditions: Polycythemia Vera;   Thrombocythemia, Essential
Intervention: Drug: No cytoreductive vs cytoreductive drugs
9 Recruiting Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   Thrombocytopenia
Interventions: Drug: Eltrombopag/Revolade;   Other: Placebo
10 Recruiting Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter
Conditions: Thrombopenia;   Central Venous Catheter Placement
Intervention: Procedure: Platelets transfusion
11 Recruiting Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults
Condition: Hemolytic Uremic Syndrome
Intervention: Biological: Extra blood draw samples
12 Recruiting Myeloproliferative Neoplastic Diseases Observatory From Brest
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Primary Myelofibrosis
Intervention:
13 Recruiting Immune Thrombocytopenia in Pregnancy
Conditions: Immune Thrombocytopenia;   Pregnancy
Intervention: Other: No intervention
14 Not yet recruiting Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)
Condition: Acquired Thrombotic Thrombocytopenic Purpura
Intervention: Biological: caplacizumab
15 Recruiting Cytopenias Autoimmune: Midi-Pyrenees Register
Condition: Immune Thrombocytopenia
Intervention: Other: no specific intervention
16 Recruiting Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients
Condition: Immune Thrombocytopenic Purpura (ITP)
Intervention: Drug: Eltrombopag
17 Recruiting Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
Conditions: Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase;   Primary Myelofibrosis
Interventions: Biological: Durvalumab;   Other: Laboratory Biomarker Analysis
18 Not yet recruiting Molecular and Clinical Profile of Von Willebrand Disease in Spain
Condition: Von Willebrand Disease
Intervention: Genetic: VWF gene analysis
19 Recruiting Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Interventions: Drug: Romiplostim;   Drug: Placebo
20 Recruiting Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia (ITP)
Intervention: Drug: Romiplostim

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years